| Genome-wide association identifies multiple ulcerative colitis susceptibility loci DPB McGovern, A Gardet, L Törkvist, P Goyette, J Essers, KD Taylor, ... Nature genetics 42 (4), 332-337, 2010 | 784 | 2010 |
| Genome-wide association identifies multiple ulcerative colitis susceptibility loci DPB McGovern, A Gardet, L Törkvist, P Goyette, J Essers, KD Taylor, ... Nature genetics 42 (4), 332-337, 2010 | 783 | 2010 |
| Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut G Melmed, LS Thomas, N Lee, SY Tesfay, K Lukasek, KS Michelsen, ... The Journal of Immunology 170 (3), 1406-1415, 2003 | 574 | 2003 |
| ACG clinical guideline: preventive care in inflammatory bowel disease FA Farraye, GY Melmed, GR Lichtenstein, SV Kane Official journal of the American College of Gastroenterology| ACG 112 (2 …, 2017 | 484 | 2017 |
| Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease DPB McGovern, MR Jones, KD Taylor, K Marciante, X Yan, M Dubinsky, ... Human molecular genetics 19 (17), 3468-3476, 2010 | 439 | 2010 |
| Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses GY Melmed, AF Ippoliti, KA Papadakis, TT Tran, JL Birt, SK Lee, ... Official journal of the American College of Gastroenterology| ACG 101 (8 …, 2006 | 382 | 2006 |
| A randomized, double-blind, placebo-controlled phase 2 study of brodalumab in patients with moderate-to-severe Crohn’s disease SR Targan, B Feagan, S Vermeire, R Panaccione, GY Melmed, ... Official journal of the American College of Gastroenterology| ACG 111 (11 …, 2016 | 341 | 2016 |
| Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis GS Hazlewood, A Rezaie, M Borman, R Panaccione, S Ghosh, CH Seow, ... Gastroenterology 148 (2), 344-354. e5, 2015 | 309 | 2015 |
| Appropriate therapeutic drug monitoring of biologic agents for patients with inflammatory bowel diseases K Papamichael, AS Cheifetz, GY Melmed, PM Irving, NV Casteele, ... Clinical Gastroenterology and Hepatology 17 (9), 1655-1668. e3, 2019 | 279 | 2019 |
| Life after radical prostatectomy: a longitudinal study MS Litwin, GY Melmed, T Nakazon The Journal of urology 166 (2), 587-592, 2001 | 272 | 2001 |
| Development of the NIH patient-reported outcomes measurement information system (PROMIS) gastrointestinal symptom scales BMR Spiegel, RD Hays, R Bolus, GY Melmed, L Chang, C Whitman, ... Official journal of the American College of Gastroenterology| ACG 109 (11 …, 2014 | 251 | 2014 |
| Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease GY Melmed, N Agarwal, RW Frenck, AF Ippoliti, P Ibanez, KA Papadakis, ... Official journal of the American College of Gastroenterology| ACG 105 (1 …, 2010 | 225 | 2010 |
| Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib KL Winthrop, GY Melmed, S Vermeire, MD Long, G Chan, RD Pedersen, ... Inflammatory bowel diseases 24 (10), 2258-2265, 2018 | 221 | 2018 |
| Biomarkers and health-related quality of life in end-stage renal disease: a systematic review BMR Spiegel, G Melmed, S Robbins, E Esrailian Clinical Journal of the American Society of Nephrology 3 (6), 1759-1768, 2008 | 210 | 2008 |
| Guidelines for the appropriate use of non‐steroidal anti‐inflammatory drugs, cyclo‐oxygenase‐2‐specific inhibitors and proton pump inhibitors in patients requiring chronic anti … RW Dubois, GY Melmed, JM Henning, L Laine Alimentary pharmacology & therapeutics 19 (2), 197-208, 2004 | 210 | 2004 |
| The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease surgery C Lau, M Dubinsky, G Melmed, E Vasiliauskas, D Berel, D McGovern, ... Annals of surgery 261 (3), 487-496, 2015 | 188 | 2015 |
| SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting CA Siegel, GY Melmed, DPB McGovern, V Rai, F Krammer, DT Rubin, ... Gut 70 (4), 635-640, 2021 | 181 | 2021 |
| Genetic predictors of medically refractory ulcerative colitis T Haritunians, KD Taylor, SR Targan, M Dubinsky, A Ippoliti, S Kwon, ... Inflammatory bowel diseases 16 (11), 1830-1840, 2010 | 171 | 2010 |
| Early infliximab trough levels are associated with persistent remission in pediatric patients with inflammatory bowel disease N Singh, CJ Rosenthal, GY Melmed, J Mirocha, S Farrior, S Callejas, ... Inflammatory bowel diseases 20 (10), 1708-1713, 2014 | 167 | 2014 |
| Quality indicators for inflammatory bowel disease: development of process and outcome measures GY Melmed, CA Siegel, BM Spiegel, JI Allen, R Cima, JF Colombel, ... Inflammatory bowel diseases 19 (3), 662-668, 2013 | 150 | 2013 |
